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Background: Delirium (or acute confusion) is a serious illness common in older people, in which a person’s thinking
and perceptions may be affected. Reducing delirium is important because of the considerable distress it causes, and
the poor outcomes associated with it, such as increased admissions to hospital, falls, mortality and costs to the National
Health Service (NHS). Preventing delirium is possible using multicomponent interventions; successful interventions in
hospitals have reduced it by one-third. However, there is little research to guide practice in care homes, where it is
common because of the clustering of known risk factors (older age, frailty, and dementia). In previous work we
developed a multicomponent intervention to prevent delirium in care homes, called Stop Delirium! The intervention
was based upon evidence from the research literature relating to the prevention of delirium and on strategies to change
professional practice. Before starting a large costly trial of Stop Delirium!, this pilot study will test and help improve the
design and feasibility of the trial protocol.
Methods/Design: We plan to conduct a cluster randomised pilot trial in 14 care homes (independent residential
and nursing). Following recruitment of residents (over 60 years, consenting or with consultee agreement, able to
communicate in English, and not in palliative care) participating homes will be randomised, stratified by size of
home and proportion of residents with dementia. Stop Delirium! will be delivered to intervention homes over
16 months, with controls receiving usual care. The primary outcome measure will be the presence of delirium on
any day during a one-month post-intervention period.
We will collect data to determine 1) recruitment and attrition rates, 2) feasibility of various outcomes measurements,
and 3) feasibility of capturing health resource use (resident diaries and by examining health records). We will
estimate the between-cluster variation for the primary outcome, delirium occurrence.
Discussion: This pilot study will refine methods for the definitive trial. The lessons learnt will also contribute to
implementing National Institute for Health and Clinical Excellence (NICE) delirium guidelines, which recommend
multicomponent interventions for delirium prevention.
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Figure 1 The individual components of Stop Delirium!
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Delirium is a distressing but preventable condition that
is common in older people. It is associated with in-
creased morbidity, mortality, functional decline, hospi-
talisation, and significant healthcare costs [1,2]. Despite
its high prevalence and poor outcomes, delirium has
been under-researched and neglected in clinical practice
[1,3]. Most research on delirium has focused on hospital
patients. Another (expanding [4]) high risk group is resi-
dents of care homes for older people. The burden of
delirium is likely to be considerable in residents of long-
term care given the clustering of known delirium risk
factors [5], especially the high prevalence of dementia.
Individuals admitted to hospital from long-term care have
higher rates of delirium [6], and institutional residence has
been identified as a risk factor for post-operative delirium
[7]. However, there have been few good-quality studies,
investigating delirium in long-term care. A systematic
review [8] found no studies of delirium incidence and no
studies from the United Kingdom (UK). The median point
prevalence of delirium was reported to be 14% in studies
reflecting the UK model of long-term care [8].
We know that delirium can be prevented (reduced by
one-third) in hospitals [9-11]. Successful interventions
are multifaceted and rely on a combination of staff
education and systematic screening for modifiable risk
factors (attending to dehydration, pain, sensory impair-
ments and poor mobility). These are areas of care that
should be equally applicable to long-term care settings. It
is not yet known, however, whether a similar approach
might be effective in care homes. The recent National
Institute for Clinical Excellence (NICE) delirium guide-
line recommends that such interventions should be
implemented in long-term care given the likely benefits.
In addition, it recommends that the clinical and cost ef-
fectiveness of these interventions should be investigated
as a research priority [12].
A further reason to focus on delirium is its link to care
quality [13], which has been a subject of concern for
some time in long-term care [14,15]; training of staff has
not kept pace with the changing demands of care homes
[16,17], and there is poorer management of medical con-
ditions, increasing the need for unplanned hospital ad-
missions and general practitioner (GP) consultations
[18]. Achieving improvements in care quality is challen-
ging [19]. Optimum delirium care is fundamentally the
provision of basic good quality supportive care [13]. For
staff inured to endless messages to improve quality, a
focus on delirium prevention may be the ‘Trojan horse’
through which this can be achieved [20]. There are add-
itional potential benefits: reducing morbidity, hospital ad-
missions and healthcare costs.
In previous work, we used the Medical Research Council
(MRC) framework for the development of complexinterventions [21] to design the ‘Stop Delirium!’ [22] inter-
vention to prevent delirium in care homes.
The Stop Delirium! intervention - essentially an enhanced
educational package for care home staff - incorporates strat-
egies to change practice, such as adapting to the local con-
text, interactive teaching methods, promoting ownership
and championing. This approach to delirium prevention is
based upon and supported by the research literature from
hospital settings and is consistent with NICE guidelines.
In preparation for this pilot trial, we have developed a
standardised Stop Delirium! toolkit including a manual
for the Delirium Practitioner and educational resources
for care home staff.
Each of the intervention elements is discrete but inter-
linked. The individual components of Stop Delirium! are
shown in Figure 1. We have now initiated a pilot trial as
the first stage in an evaluation programme for this com-
plex intervention. A flowchart of the trial procedure is
shown in Figure 2.
Aims and objectives
The primary hypothesis for the main trial will be that Stop
Delirium! is a cost-effective way to prevent delirium epi-
sodes in residents of older people’s care homes. The sec-
ondary hypothesis will be that this will lead to a reduction
in admissions to hospital from this population. The main
objective of this pilot trial is to gather process, manage-
ment, resource and scientific data to inform the design of a
definitive trial. The principle objectives of this pilot and the
corresponding research questions are outlined in Table 1.
Methods/Design
Design
We plan a pilot cluster, randomised, controlled trial con-
ducted in 14 care homes for older people over 24 months,
Figure 2 Flowchart of the PiTStop trial procedure.
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vidual and focus group interviews to investigate sustain-
ability and integration of the intervention.
Population
The study will be conducted within the boundaries of
Bradford Metropolitan District Council, West Yorkshire,
in the north of England.
Inclusion criteria for care homes
The inclusion criteria for care homes will be as follows:
1. Care homes for older people in Bradford (nursing
and residential)
2. Run by an independent provider (private, voluntary
or non-profit making)3. Within catchment area for Bradford District Care
Trust Older People’s Community Mental Health
Teams
Exclusion criteria for care homes
The exclusion criteria for care homes will be as follows:
1. Local Authority homes - these are homes run by local
government. The number of care homes for older
people run by local authorities is decreasing and the
money is being transferred to third party providers.
Therefore, it is believed that the intervention is less
likely to be implemented in local authority homes.
2. Specialist homes (those focusing on stroke
rehabilitation, except for those specialising in
providing dementia care)
Table 1 Principle objectives, research questions and outcomes
Principle objectives Research questions Outcomes
Process: To provide an estimate for the number
of care homes needed for the main trial
What are the potential recruitment and attrition
rates for enrolment of residents?
Resources: To investigate the acceptability of
the proposed measurements to residents and
the most appropriate informant
Which type of data collection diaries (care
home resident level), designed by the team
to capture health and social care resource use,
are most acceptable to residents and staff
(>75% completed)? And are these diaries valid
(contain information that can be used to
calculate costs)?
Activities of daily living Number of falls during
previous 6 months
Mortality during previous 6 months
Hospital admissions during previous 6 months
including total length of stay; number of
admissions; time to first admission
Health-related quality of life
Which health-related quality of life measure,
the EuroQol (EQ-5D 3 L) [23], ASCOT Social
Care-Related Quality of Life (SCRQoL) [24] or
the DEMQOL-V4 [25] is more acceptable to
residents (greater % of questionnaires
completed)? And are resident and proxy
reports of HRQoL comparable?
Are baseline and outcomes measures outcome
rates adequate (achieving >75% complete data
for each)? And what resources are required in
determining these outcomes?
Management: To assess the adherence to,
and sustainability of Stop Delirium!
What are the adherence rates for the various
components of the intervention? And what
are the facilitators and barriers for sustainability
and integration into routine care, after the
intervention?
Total number of medications Health related
quality of life Health and social care costs as
measured by health related quality of life
measures and health and social care resource
use
What are the costs from the perspective of
the service provider (health and social care)
associated with delirium and with Stop Delirium?
Scientific: To determine the most appropriate
method to capture resource use in this setting
and population and costs of delirium and of
delivering the intervention
Can a high (>90%) coverage for delirium
screening be achieved using the short
Confusion Assessment Method (CAM) [26]?
And can a high completion rate (>90%
complete) be achieved for the Delirium Rating
Scale-Revised (DRS-R-98) [27] in those positive
for CAM? Is delirium be determined reliably
(>90% inter-rater reliability) using these
instruments?
Delirium severity: proportion of residents with
severe delirium during a one-month period
Delirium duration (days positive for delirium)
during a one month period
Delirium incidence on any on any day during
a one-month post-intervention period
Mortality during previous 6 months
Hospital admissions during previous 6 months
including total length of stay, number of
admissions, time to first admission
What are the rates of delirium and admission
to hospital in residents in intervention homes
compared to control homes post intervention?
And which measure yields more complete
hospital admission data: length of stay, number
of admissions or time to admission?
To estimate the rates of delirium and hospital
admissions in intervention and control homes
What is the intraclass coefficient (ICC) for the
proposed primary outcome, delirium
occurrence?
The primary outcome for this study is the
presence of delirium on any day during a
one-month post intervention period
determined by screening with short version
CAM [26] on alternate days (except Sundays)
and confirmed for those positive or borderline
using the Delirium Rating Scale-98 (DRSR98) [27].
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Inclusion criteria for residents
All residents present in the care home at the time of
baseline assessments will be considered for participation.Exclusion criteria for residents
The exclusion criteria for residents will be as follows:
1. Unable to participate in assessments because of
severe communication difficulties or severe
dementia.
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3. Non-English speakers
Whilst we recognise that the exclusion of non-English
speakers is restrictive, we feel that it is appropriate
at this trial stage. The number of Black and Minority
Ethnic elders in Bradford care homes is thought to
be low and the validated assessment tools are not
available in South Asian languages. Recruitment will
be monitored to ascertain how many people are ex-
cluded for this reason to inform the inclusion criteria
of a future trial.Sample size
For a definitive trial, in the absence of empirical data
on which to base an estimate of effect size from care
homes, we plan to extrapolate from results obtained in
hospital studies [9,10]. This approach is reasonable given
similarities in the population and processes of care.
Although care home residents may be less physically
unwell, limiting the scope for impact, this is balanced
by increased opportunity for staff to benefit from train-
ing and improve practice [17,28] and for residents to
receive greater benefit due to longer exposure staff
practice changes than is the case for short admission
spells in hospitals.
For an individually randomised trial, 809 participants
would be required per group to provide 80% power at
5% significance level to detect a reduction of one-third
in delirium rates (found in delirium prevention studies
in hospital settings). The assumed control rate of delir-
ium is 14% (the median-point prevalence of delirium
found in our literature review [8]).
The attrition rate would reduce the number of partici-
pants with a valid outcome within a site (cluster) and
therefore affects the cluster size. When designing a clus-
ter randomised trial, the cluster size, together with the
intraclass coefficient (ICC), is used to estimate the de-
sign effect, which increases the sample size (compared
to an individually randomised trial) to account for the
clustering of outcomes.Recruitment
Care home recruitment
Eligible care homes in the Bradford District will be iden-
tified from the Care Quality Commission (CQC) public
listing and the managers invited to return an expression
of interest (EOI) in the study by post. Homes returning
a positive EOI and non-respondents will be followed up
with a telephone call. Care home managers who confirm
their interest or have further queries will be visited in
person to explain the study objectives, timescales and
involvement required.Resident recruitment
Care home managers will be asked to identify eligible
residents in their care home. For those clearly not eligible,
the following non-identifiable data will be recorded: care
home, age, sex, ethnicity, and reason for exclusion.
All eligible residents will be asked by care home staff if
they are willing to be seen by researchers so they can ex-
plain the study. If they agree, a researcher, accompanied
by a member of care home staff will then explain the
study to the resident and assess for capacity to consent.
If residents have capacity they will be asked for consent
to participate in the study. Residents who consent will
also be asked about their views on future participation
should their capacity fluctuate (through worsening de-
mentia or a delirious episode). For residents without
capacity, the advice of a consultee will be sought if there
is no advanced directive in place pertaining to participa-
tion in research.
A protocol amendment has been put in place in
order to undertake further recruitment of residents
at 12 months post-intervention (2 to 4 months prior to
the outcomes assessments). This will mitigate the effect
of attrition in this extremely frail and elderly population
and subsequent loss to follow-up. It will also allow us to
investigate the feasibility of alternative approaches to the
timing of recruitment.
Additional recruitment will take place in all care
homes participating in the study. Care will be taken to
spread additional recruitment over both the intervention
and control arms. Residents will only be considered
for recruitment at this stage if they have moved into
the home subsequent to the first round of recruitment
(those who have already been approached and refused
will not be approached again). All other eligibility criteria
will apply.
Additional residents will be recruited during the
intervention and will provide baseline and follow-up
assessment data in the same way as those recruited
earlier.
We are conscious that a two-tier recruitment strategy
may lead to differential recruitment, as randomisation to
the intervention or control arm has already taken place;
however, additional recruitment will not be used as a co-
variate in analyses.
Randomisation
Homes will be randomised on a 1:1 basis to receive
either active intervention (Stop Delirium!) or control
(usual care) by the Leeds Clinical Trials Research Unit
(CTRU), stratified by care home size (<20 or under, ≥20
residents) and the percentage of residents with dementia
(<62%, ≥62%). Randomisation will take place only after
the baseline recruitment and assessment of residents
have been completed for each home.
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Due to the nature of the intervention, it will not be pos-
sible to blind participants or the research team to alloca-
tion. Outcome measures will be collected by researchers
having no role in the intervention and having no explicit
knowledge of the allocations.
Intervention
Stop Delirium!
Intervention homes will receive the Stop Delirium! pack-
age. This is a multicomponent intervention designed to
prevent delirium in care home residents, based on the
best delirium prevention and practice change evidence.
It aims to modify key resident and environmental delir-
ium risk factors (pain, infections, dehydration, poor nu-
trition, constipation, polypharmacy, sensory impairment,
limited mobility and sleep disturbance) by improving the
quality of care. A specialist delirium practitioner (DP)
leads a delirium prevention educational process such
that care home staff feel empowered, develop relevant
skills and are able to identify opportunities for delirium
prevention through the development of local care path-
ways and solutions tailored to the home environment.
Key components (tested and refined in our previous
feasibility study [22]) include:
1. Three 20-minute small group interactive education
sessions for all staff in the home delivered by the DP
and then offered monthly to new staff.
2. Monthly Staff Working Groups facilitated by the DP
to identify key priority areas for delirium prevention
in the home. Participants are drawn from staff
volunteers attending education sessions.
3. A Delirium Box containing educational and
implementation materials is established in each
home by the home manager, supplemented by
bespoke materials produced by staff members of the
care home Working Groups.
4. The identification of delirium champions by the DP,
who are then trained to deliver the education
sessions and to facilitate Staff Working Groups
under supervision, with a view to sustaining the
intervention.
5. A manualised intervention to provide a consistent
educational experience and approach to developing
the workshops. Specific features of the intervention
can be found on the European Delirium Association
website [29].
The intervention will be in place for 16 months. This
is 6 months longer than was allowed for in the previous
feasibility phase. This period is intended to provide suffi-
cient time for any change in practice to embed and have
an effect.Control
Residents in control homes will receive ‘usual care’
during the study but care homes will be offered the
intervention at study end.
Outcomes
Outcomes aligned to the feasibility objectives and re-
search questions are detailed in Table 1.
Data collection
Data will be collected electronically at each of the 14
care home sites, using portable, password-protected,
encrypted devices (tablets). Each tablet will be config-
ured to ease the burden on residents by allowing pre-
population of data fields (where information has already
been gathered by another assessment tool) and to allow
intermittent breaks in data collection if necessary. System
checks will flag all missing data to the researcher in real
time which will ensure that the data sets are as complete
as possible.
For each home in the study the following information
will be recorded at baseline:
Care home data
Data collected from the care home records will include:
1. Name of provider.
2. Type of care (nursing only or nursing and
dementia).
3. Number of residents.
4. Number of staff, including skill mix.
5. Hospital admissions over the previous 6 months.
6. Falls over the previous 6 months.
7. Any current educational programmes or other
relevant initiatives.
Resident data
Screening and baseline data for residents will be col-
lected before randomisation. Post-intervention outcome
data will be collected at 16 months post-randomisation.
Screening
The following anonymised screening, information will
be collected for all residents within the care home: gen-
der, age, ethnicity and eligibility for inclusion. Reasons
for non-eligibility will be recorded.
Baseline assessments
For all residents recruited, the following information will
be recorded through examining care home records or
administering tests. Baseline assessment data will include:
1. Initials
2. NHS number and hospital ID
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4. Age
5. Sex
6. Medications - total number and names
7. Co-morbidities (Charlson index [30])
8. Activities of Daily Living (ADL) [31]
9. Hearing Impairment
10. Visual impairment (Snellen test card at 3 meters,
acuity below 6/18 assessed as visually impaired)
11. EuroQoL EQ-5D and EQ5D proxy [23]
12. Either the Social Care Related Quality of Life
(SCR-QoL) [24] or Dementia Quality of Life
DEMQOL and DEMQOL-Proxy [25]
13. Delirium
Delirium assessments will be undertaken using a three
step process:
1. Assessment of cognitive impairment using the Six
Item Cognitive Impairment Test (6-CIT) [32,33]
2. Short Confusion Assessment Method (CAM) [26]
3. In those screening positive on CAM, the Delirium
Rating Scale Revised-98 (DRS-R-98) [27] (using a
cut-off score of >17.75)
Post-intervention assessments
Researchers, blind to allocation, will collect data 16 months
from randomisation - deemed to be the start of the
intervention - through administering tests on alternate
days (except Sundays) for a period of one month and
examining individual care home and hospital records.
Researchers will record;
1. Presence of delirium on any day during a 1-month
post-intervention period. Screening will use the 6-CIT
and short version CAM. Presence or absence of
delirium for those positive will be confirmed
using the DRS-R-98 (as at study baseline). Ratings
for a 10% subsample will be compared to determine
inter-rater reliability.
2. Delirium severity (proportion of residents with DRS-
R-98 severity scale score >15.25 at any assessment)
during the 1-month post-intervention period.
3. Delirium duration (days positive for delirium) during
the 1-month post-intervention period.
4. Number of medications.
5. Activity of Daily Living (ADL) scores.
6. Falls during previous 6 months.
7. Mortality during previous 6 months.
8. Hospital admissions during previous 6 month
including;
a. total length of stay
b. number of admissions
c. time to first admissionThe 6-CIT is a dementia screening tool used in primary
care. The short CAM is a four-question instrument used
extensively for delirium screening and diagnosis [26]. The
DRS-R-98 is a valid measure of delirium occurrence and
severity [27]. We know that the training of the researcher
affects performance of these instruments [34]. Researchers
will be trained before both the baseline and post-
intervention assessments. As part of the analysis, we will
also check inter-rater reliability at baseline by comparing
ratings for a 10% subsample.
If a resident scores positive on the short CAM, indi-
cating a possible delirium, subject to prior consent, the
care home manager will be informed in writing on the
day of assessment so that appropriate action can be
taken. A copy of this letter will be held on file with the
consent forms.
Acceptability and burden of assessments
Time taken for completion of assessments will be recorded
contemporaneously. Rates of completion for all outcomes
measures or reason for noncompletion will be recorded. In
addition, note will be taken of who completes the health-
related quality of life measures (residents or proxies (carer
or relative)).
Treatment data
Intervention compliance. Adherence to the compo-
nents of the intervention at 4, 8 and 16 months from
randomisation - early middle and late phases of delivery -
will be recorded using a standardised pro-forma. Data
recorded will include degree of completion for each com-
ponent (education sessions, working groups) and reasons
for noncompliance, allowing calculation of adherence rates
for each, and identification of components that may need
alteration before use in a definitive trial.
Concomitant interventions. Any new initiatives or pro-
jects introduced during the study period by other agents
(researchers, health organisations or local authorities-
especially those aimed at reducing hospital admissions
and falls - will be recorded at 4, 8 and 16 months from
randomisation).
Outcomes for the economic evaluation
Health and social care use by residents will be recorded
using specifically designed data collection forms/diaries.
Data will be collected at 4, 8 and 16 months from ran-
domisation. Contemporaneous study records (of salaries
and travel expenses) will be kept to determine resource
use in implementing the intervention. We will collect
the bulk of resource use data from care home records
but will test the accuracy of this method by comparing
the results with those from a subset of individual
resident care records and with centralised records of
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Social Care Information Centre (HSCIC).
Unit financial costs for health and social care re-
sources will be obtained from national sources (Personal
Social Services Research (PSSRU) Unit Costs of Health
and Social Care, British National Formulary (BNF) and
NHS reference cost databases) and used to determine
costs. Utility (HRQoL) values will be determined from
either EQ5D-3 L, SCR QoL or DEMQOL-P-4D.
Interviews
We will investigate opportunities and barriers to sustain-
ability for Stop Delirium! and its integration into routine
practice through qualitative interviews with key staff.
Focus groups will take place at the start and end of the
intervention period. Two groups will comprise either
nursing or care staff from across all intervention homes.
Individual interviews with a manager and a Delirium
Champion from each intervention home will take place
16 months from randomisation.
Analysis
In this pilot trial, quantitative analysis will focus on de-
scriptive statistics and will focus on confidence interval
estimation rather than formal hypothesis testing. An
intention-to-treat-analysis of clinical data will be under-
taken blind to allocation. Any statistical analysis in a
definitive trial would include multilevel modelling to
account for the cluster design. Qualitative data from in-
terviews and focus groups will be analysed combining a
grounded theory (constant comparison) approach and
narrative analysis to develop understanding of the factors
(such as contextual, leadership, and organisational struc-
tures and knowledge, beliefs and behaviours of staff) that
facilitate or inhibit sustainability of the intervention and its
integration into routine practice over time.
Baseline assessments
A preliminary analysis consisting of a series of descrip-
tive tables summarising baseline characteristics of a) the
14 care homes and b) residents in the study will be pre-
sented. Summary and comparison statistics will be used
to describe and compare the intervention and control
arms. The baseline delirium prevalence (residents posi-
tive for delirium/total number of residents screened) will
be determined from the baseline data.
Outcome assessments
The delirium occurrence rate for intervention and for
control arms will be calculated (number of residents
with an episode of delirium in one month/total number
of residents screened). A 95% confidence interval for the
difference in rates will be constructed. Intraclass coeffi-
cients will be calculated for delirium occurrence usingdata from the post-intervention period. Summary statis-
tics and comparisons between the intervention and con-
trol arms post-intervention will also be calculated for all
primary and secondary outcomes as detailed previously.
Recruitment and attrition will be summarised, together
with rates of consent, consultee consent, withdrawals and
deaths. In addition, Kaplan-Meier survival curves will be
constructed for the following outcomes:
1. Time to first hospital admission in previous
6 months.
2. Mortality in previous 6 months.
Outcomes for hospital admission and mortality are
assessed starting 10 months after randomisation. This is
because we hypothesise that the intervention will not be
able to influence outcomes before that time as it pro-
vides education for staff, which they need to operational-
ise into actions that will then affect residents. We have
not therefore collected data for events occurring between
randomisation and 10 months for hospital admission. We
will have information on deaths and will present a sum-
mary of these data for the intervention and the control
homes.
Data from the first and second stages of resident
recruitment will be analysed together with a separate
sensitivity analysis to investigate the impact of the later
phase.
Data quality
The quality of the data will also be assessed using markers
for completeness and reliability (completion rates of delir-
ium screening and rating instruments and measures of
inter-rater reliability). In addition, we will determine which
variable yields more complete hospital data: length of stay,
number of admissions or time to admission.
Patient and public involvement
A number of patient and public involvement strategies
have been used to inform the development and conduct
of the study. The opinion of members of the Bradford
Older People’s Forum was sought in developing the
study proposal. Two care home managers from the feasi-
bility phase along with a Care Home Quality Visitor and
a relative of a care home resident are members of the
Advisory Board, which has a monitoring role. Care home
residents have also reviewed written and audio-visual
material for use in recruitment of residents at the design
stage. Lay representatives with specialist interest sit on
the Implementation Team that steers the project and are
involved in the production of information, raising aware-
ness with residents, relatives and care home staff; they
will also be involved in the facilitation of focus groups
with care home staff.
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rienced and involved in other similar activities (represen-
tatives on other Boards and committees in health and
social care). All lay representatives were given the study
protocol and background reading on delirium before
involvement and will be recompensed for their time in
accordance with INVOLVE recommendations [35]. Care
homes will receive a one-off payment of £400 in recogni-
tion of the staff input.
Trial governance
A multidisciplinary Implementation Team will guide the
operational management of the trial, with responsibility
for overall supervision of the study on behalf of the trial
sponsor (Bradford District Care Trust) and trial funder
(NIHR). The team comprises lay representatives, statisti-
cians, health economists, trial managers, consultants in
older people’s care, and experts in complex interventions
and qualitative studies. In addition, an independent
Advisory Board, chaired by the National Clinical Director
for Older People, and including two lay representatives,
two care home managers (independent of sample), experts
in older people’s care and care homes, will oversee the trial.
The primary role of the Advisory Board is ‘to ensure that
the rights, safety and well-being of the trial participants are
the most important considerations, and prevail over the
interests of science and society.’
This trial is being conducted in accordance with
the principles of Good Clinical Practice and the NHS
Research Governance Framework and all data are held in
accordance with the Data Protection Act and Caldicott
principles.
The study protocol received ethical approval from the
Yorkshire and Humber Research Ethics Committee on
24/01/2012 (ref: 12/YH/0018). Further approval was given
for additional recruitment and a change of quality of life
assessment tool on 11/02/2013.
Discussion
We have made the following modifications to the
original planned protocol: i) increased the number of
homes to be included from 12 to 14; ii) included
residential as well as nursing homes; iii) introduced
additional recruitment of residents at 12 months post-
randomisation of homes (2 to 4 months before the post-
intervention outcomes assessments); and iv) replaced the
SCRQoL with the DEMQOL at post-intervention data
collection. These changes will help us investigate the feasi-
bility of alternative approaches to recruitment and quality
of life assessments. Modifications have been agreed on by
the study sponsor and funder, and have received Ethics
Committee approval.
Although yet to be confirmed by the results of this
pilot trial, we anticipate that the definitive trial will havea shorter intervention period (between 10 to 16 months),
that recruitment of residents will take place nearer to
the outcome assessments, and that an alternative method
of delirium screening will be used.
Trial status
Recruitment is ongoing. The second stage of recruitment
started in May 2013.
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